
We're looking for a proactive and detail-oriented Regulatory Affairs Associate - Compliance to join our team at Sandoz Australia on a full-time basis.
In this role, you will support regulatory labelling and related document compliance activities across the Australia and New Zealand portfolio. You'll work closely with local and global stakeholders to ensure product labelling remains accurate, compliant, and aligned with regulatory requirements throughout the product lifecycle.
As part of the Regulatory Affairs team, you'll contribute to high-impact outcomes by:
Major Accountabilities
What You'll Bring to the Role
Commitment to Diversity & Inclusion
Sandoz is committed to building an outstanding, inclusive work environment and diverse teams that are representative of the patients and communities we serve.
Generic and biosimilar medicines are the backbone of the healthcare industry, and Sandoz touches the lives of nearly 500 million patients globally each year. While we are proud of this impact, we are driven to do more. Through investments in development capabilities, state-of-the-art production sites, strategic acquisitions, and partnerships, we are shaping the future of affordable, high-quality medicines.
Our momentum is powered by an open, collaborative culture and a team of talented, ambitious associates. We foster an agile and inclusive environment where diversity is valued, innovation is encouraged, and personal growth is supported.
Locally, we are proud to be certified as a Great Place to Work® for the third consecutive year. In 2023 and 2024, we were recognised as one of the Top 50 Australian Companies on the Great Place to Work for Women list and ranked #2 in Australia's Best Workplaces in Biotechnology & Pharmaceuticals 2024.
The future is ours to shape.
#Sandoz
Skills Desired
Detail-Oriented, Labeling Documentation, Labeling Regulations, Operational Excellence, Regulatory Compliance, Safety

Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients.
More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz annually, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer.
Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion.
Read our community engagement guidelines: http://bit.ly/4ofoggc